Research in Action

Research in Action

By Oracle CorporationNewsTechnologyTech News
Download on the App Store

Research in Action episodes

  • In silico screening, virtual drug discovery and computational tools

    What is in silico drug design? And what role is it playing in drug discovery? How is cloud computing removing the limitations for in silico screening? We will learn those answers and more in this week's episode with Dr. John Bruning, a Senior Lecturer in the School of Biological Sciences at the University of Adelaide in Southern Australia, where he also founded the University's laboratory of protein crystallography. Dr. Bruning is also an Oracle for Research Fellow and was named a finalist for the 2022 Oracle Excellence Award in the Eureka Award category. Dr. Bruning received his Bachelor of Science from Texas A&M University and his PhD from Rice University. He has completed two post-doctoral research positions in structure guided drug design at the Scripps Research Institute and the Texas A&M Health Science Center in the Houston Medical Center. His research has been cited in numerous peer-reviewed journals.

    You can learn more about Dr. Bruning and his work here: https://researchers.adelaide.edu.au/profile/john.bruning

    Learn more about Oracle for Research: http://www.oracle.com/research

    29 min
  • Let's talk AI, LLMs, and the future of research

    How did we get where we are today with AI and machine learning? What are the ways Large Language Models (LLMs) can be applied to healthcare? And what about that suggested pause on advanced AI? We will explore those questions and much more in this episode with Dr. James Benoit, a postdoctoral researcher at the Women and Children's Health Research Institute (WCHRI) in Canada, where his research focuses on the use of Large Language Models (LLMs) and artificial intelligence to improve healthcare outcomes. He earned his Bachelor's and Master's from the University of British Columbia, where he studied Applied Ethics and Integrated Science; and he earned his PhD in Psychiatry at the University of Alberta. He has years of research experience, including time as a Research Fellow at Harvard Medical School. His current work involves leveraging large language models (LLMs), such as GPT-4, to develop tools for clinical decision-making and patient care.

    36 min
  • How patient-led research and citizen scientists are advancing scientific discovery
    How can patients and their families become more integral in the research process and drug discovery? How can citizen scientists and patient-led research become more accepted in the scientific community? And who qualifies as a citizen scientist? We will tackle those questions and much more in this episode with Amy Dockser Marcus, a Pulitzer Prize-winning journalist and author of the recently published book, "We The Scientists: How a daring team of parents and doctors forged a new path for medicine." Amy is a veteran reporter at the Wall Street Journal and won her Pulitzer Prize for Beat Reporting in 2005 for her series of stories about cancer survivors and the social, economic, and health challenges they faced living with the disease. She has covered science and health at the Journal for years, and she also earned a Master of Bioethics from Harvard Medical School. Learn more about Amy and her new book: https://www.wsj.com/live-qa/amy-dockser-marcus-on-her-new-book-we-the-scientists/4BFE8957-882E-4C93-B335-7151B8411310
    37 min
  • Helping scientific and evidence-based research go faster for pharma with startup ingenuity

    What are the obstacles to faster pharmaceutical and medical research? And is there such a thing as a comprehensive biomedical search and AI engine? We will learn those answers and more with guest Matteo Ghetti, cofounder of Sweden-based startup PapersHive. PapersHive is a biomedical search and AI engine to help researchers and medical professionals get to scientific research evidence faster. And this matters a lot with the emergence of evidence-based medicine making R&D in drug development and medical device design more arduous, demanding researchers to consult many tens, hundreds, or thousands of scientific publications. We also talk about Matteo and his co-founders' journey from ideation to a disruptive startup. We are proud that Oracle for Research has played a role in the PapersHive journey. Learn more about how Oracle for Research can help you speed up your research with grants, cloud computing, and hands-on support and expertise: http://www.oracle.com/research

    29 min
  • Orthopedic surgeons use machine learning to predict better patient outcomes and reduce costs
    How is machine learning helping orthopedic surgeons predict better outcomes for patients? And how can those algorithms help predict how bone fracture surgery is approached? We will get those answers and much more on this episode with Dr. Akash Shah, Resident Physician in the Department of Orthopaedic Surgery at UCLA Medical Center. Dr. Shah received his Bachelor of Science at Duke University, and he went on to graduate from Harvard Medical School. He is also part of the team in the Department of Orthopaedic Surgery at the University of California, Los Angeles, that is working with international collaborators to build advanced machine learning (ML) models for hip and long bone fractures research. Dr. Shah and team received a grant from Oracle for Research to advance their research using Oracle Cloud to run high-powered ML models. Learn more about how Oracle for Research can help you speed up your research with grants, cloud computing, and hands-on support and expertise: www.oracle.com/research
    31 min
  • Making Open Science and Open Data the new normal with the RDA's Hilary Hanahoe

    How is Open Data and Open Science being encouraged and nurtured across the global research community? What are the biggest challenges and benefits? And how are industry players like Oracle helping? We'll be exploring those questions and much more with Hilary Hanahoe, Secretary General of the Research Data Alliance (RDA). RDA is a global community-driven organization with the goal of building the social and technical infrastructure to enable open sharing and re-use of data. As Secretary General, Hilary's responsibilities include leadership of RDA's membership, management of the RDA organization, engagement with stakeholders, and sustainable stewardship of their high-impact global community. Oracle is a member of the RDA and is currently undergoing research projects with the RDA to advance industry best practices and promote FAIR data principles. Learn more about how Oracle for Research can help you speed up your research with grants, cloud computing, and hands-on support and expertise. http://www.oracle.com/research. Learn more about the RDA: https://rd-alliance.org

    32 min
  • How Human Activity Recognition (HAR), wearables, and AI are helping in the fight against Parkinson's Disease

    What is Human Activity Recognition and why is it so important for Parkinson's research? What is the relationship between freezing of gait or FOG and brain circuitry? And how are edge computing, wearables, AI, and self-reporting helping researchers in the fight against Parkinson's? We'll be exploring those questions and much more with two Emory University professors focused on better understanding Parkinson's to help push toward a cure. Dr. Lucas McKay is an Assistant Professor of Biomedical Informatics and Neurology at the Emory University School of Medicine. He also holds a courtesy position and receives funding from the Biomedical Engineering Department at Emory/Georgia Tech. Dr. Hyeok Kwon is a post-doctoral fellow at the Department of Biomedical Informatics at Emory University and received his Ph.D. in computer science at the School of Interactive Computing at Georgia Tech. His research is focused on human-centered artificial intelligence systems and the application of computational analysis in the domain of health-related behaviors. The two were recently awarded an Oracle for Research cloud computing award to further their research around Parkinson's disease. Learn more about how Oracle for Research can help you speed up your research with grants, cloud computing, and hands-on support and expertise. http://www.oracle.com/research

    39 min
  • Talking viruses, pan-coronavirus antivirals, and the importance of in silico design

    What was it like to keep research work going during the worst of the pandemic? And how close are we to a vaccine that works against all current and future coronavirus variants? We will discuss that plus biochemistry, biosystems, and in silico design in this episode with Dr. Imre Berger. Dr. Berger is a professor of Biochemistry at the University of Bristol; Director for the Max Planck Bristol Centre for Minimal Biology; and co-founder and chief strategy officer at Halo Therapeutics, a University of Bristol spin-out. He has been published in countless scientific and academic journals, and his work covers multiple areas of biochemistry. His recent work has been focused on coronaviruses, specifically developing pan-coronavirus antivirals at Halo Therapeutics. Learn more at www.halo-therapeutics.com Learn more about how Oracle for Research can help you speed up your research with grants, cloud computing, and hands-on support and expertise. www.oracle.com/research

    37 min
  • A vital medical imaging technique is getting a major reconstruction, thanks to researchers at the University of Texas at Austin.

    A vital medical imaging technique is getting a major reconstruction, thanks to researchers at the University of Texas at Austin. Assistant Professor Jon Tamir and his team at the University of Texas at Austin are developing fast, robust, and standardized MRI reconstruction methods for faster and cheaper diagnosis and monitoring that can be used across many institutions with disparate system hardware and clinical needs. This is our Oracle for Research short that gives you a download on exciting research in only two minutes.

    3 min
  • What happens when data science meets cell biology? One researcher at the University of Bristol is finding out.

    What happens when data science meets cell biology? One researcher at the University of Bristol is finding out. Ioana Gherman, PhD student at the University of Bristol, is applying mathematical modeling and machine learning to create and analyze whole-cell models – learn how in this mini episode. This is our Oracle for Research short that gives you a download on exciting research in only two minutes.

    3 min

About Research in Action

From the publisher's feed

"Research in Action" explores the dynamic world of life sciences, covering drug discovery, clinical trials, therapeutic development, and the pivotal role of real-world data and technology in…